The common D302H variant of CASP8 is associated with risk of glioma

Lara Bethke, Kate Sullivan, Emily Webb, Anne Murray, Minouk Schoemaker, Anssi Auvinen, Anne Kiuru, Tiina Salminen, Christoffer Johansen, Helle Collatz Christensen, Kenneth Muir, Patricia McKinney, Sarah Hepworth, Polyxeni Dimitropoulou, Artitaya Lophatananon, Maria Feychting, Stefan Lönn, Anders Ahlbom, Beatrice Malmer, Roger HenrikssonAnthony Swerdlow, Richard Houlston

46 Citationer (Scopus)

Abstract

Caspase 8 (CASP8) is a key regulator of apoptosis or programmed cell death, and, hence, a defense against cancer. We tested the hypothesis that the CASP8 polymorphism D302H influences risk of glioma through analysis of five series of glioma case patients and controls (n = 1,005 and 1,011, respectively). Carrier status for the rare allele of D302H was associated with a 1.37-fold increased risk (95% confidence interval, 1.10-1.70; P = 0.004). The association of CASP8 D302H with glioma risk indicates the importance of inherited variation in the apoptosis pathway in susceptibility to this form of primary brain tumor.

OriginalsprogEngelsk
TidsskriftCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Vol/bind17
Udgave nummer4
Sider (fra-til)987-9
Antal sider3
ISSN1055-9965
DOI
StatusUdgivet - apr. 2008
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'The common D302H variant of CASP8 is associated with risk of glioma'. Sammen danner de et unikt fingeraftryk.

Citationsformater